Data / Form D filings / Ovelle Bio Corp.
Ovelle Bio Corp.: Form D filing
Ovelle Bio Corp., a biotechnology company in Dover, DE, filed a Form D with the SEC in 2026. The latest, on June 10, 2026, reports $7 million sold of a $9.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 850 NEW BURTON ROAD SUITE 201, Dover, DE, 19904
- Phone
- (800) 483-1140
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2139798
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | New notice | $9,200,000 | $7,000,000 | $2,200,000 | 1 | Jun 2, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Travis Carleton Potter | Executive Officer | |
| Merrick Pierson Smela | Executive Officer |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ovelle Bio Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.